Please check your internet connection and try again.
# Magnesium Sulfate
## Overview
Magnesium sulfate is an electrolyte that plays a crucial role in various cellular functions, including neuromuscular transmission and cardiac excitability.
## Primary Indications
* Treatment of hypomagnesemia.
* Prevention and treatment of seizures in preeclampsia and eclampsia.
* Management of torsades de pointes.
* Bronchodilator in severe asthma exacerbations (adjunctive therapy).
## Adult Dosing
* **Hypomagnesemia:**
* **Severe deficiency (serum magnesium < 1.3 mEq/L or < 0.65 mmol/L):** 4-6 grams (32-48 mEq or 16-24 mmol) intravenously over 5-10 minutes, followed by a continuous infusion of 1-2 grams/hour (8-16 mEq or 4-8 mmol/hour) for up to 24 hours or until serum magnesium is corrected.
* **Less severe deficiency:** 2-4 grams (16-32 mEq or 8-16 mmol) intramuscularly or intravenously every 4-6 hours.
* **Preeclampsia/Eclampsia:** Loading dose: 4-6 grams (32-48 mEq or 16-24 mmol) intravenously over 5-10 minutes. Maintenance infusion: 1-2 grams/hour (8-16 mEq or 4-8 mmol/hour). Intermittent intramuscular dosing (10g IM divided into two 5g doses in alternate buttocks) may be used if infusion is unavailable.
* **Torsades de Pointes:** 1-2 grams (8-16 mEq or 4-8 mmol) intravenously as a bolus over 5-10 minutes, followed by an infusion of 2-4 grams (16-32 mEq or 8-16 mmol) in 1 liter of IV fluid over 1 hour.
* **Asthma Exacerbation:** 1-2 grams (8-16 mEq or 4-8 mmol) intravenously over 15-30 minutes.
## Pediatric Dosing
* **Hypomagnesemia:** Dosing is variable and depends on severity and clinical context. A common intravenous regimen is 25-50 mg/kg/dose (2-4 mEq/kg/dose or 1-2 mmol/kg/dose) over 5-10 minutes, not to exceed 2 grams per dose, followed by an infusion. Refer to institutional protocols or specialized pediatric resources.
* **Preeclampsia/Eclampsia:** Not typically used for routine management; consult specialized obstetrical guidelines.
* **Torsades de Pointes:** 25-50 mg/kg/dose (2-4 mEq/kg/dose or 1-2 mmol/kg/dose) intravenously, not to exceed 2 grams per dose.
* **Asthma Exacerbation:** 25-50 mg/kg (1-2 mEq/kg or 0.5-1 mmol/kg) intravenously over 15-30 minutes. Maximum dose typically 2 grams.
## Dose Adjustments
* **Renal Impairment:** Magnesium is renally excreted. Use with caution in patients with renal impairment. Reduce dose and monitor serum magnesium levels closely. In severe renal impairment, avoid parenteral administration if possible.
## Contraindications
* Hypermagnesemia.
* Heart block (unless a pacemaker is present).
* Myocardial infarction.
* Severe renal impairment.
* Shock.
## Adverse Effects
* **Common:** Flushing, warmth, hypotension, nausea, vomiting, decreased deep tendon reflexes.
* **Serious:** Respiratory depression, cardiac arrest, hypermagnesemia (especially with impaired renal function), hyperthermia.
## Key Drug Interactions
* **Neuromuscular Blockers:** May potentiate neuromuscular blockade.
* **Calcium Channel Blockers:** Additive hypotensive effects and potential for myocardial depression.
* **Tetracyclines and Quinolones:** Magnesium may decrease absorption; administer these antibiotics at least 2 hours before or 4-6 hours after magnesium.
* **Digitalis:** May precipitate digitalis toxicity in patients with hypermagnesemia.
## Monitoring
* **Serum Magnesium Levels:** Frequently monitor, especially during infusions and in patients with renal impairment. Aim for 2.5-4 mEq/L (1.25-2 mmol/L) for hypomagnesemia treatment.
* **Renal Function:** Assess baseline and monitor.
* **Deep Tendon Reflexes:** Monitor for loss of reflexes, an early sign of hypermagnesemia.
* **Respiratory Rate:** Monitor for signs of depression.
* **Blood Pressure:** Monitor for hypotension.
* **Urine Output:** Monitor for adequacy, especially in patients with renal impairment or receiving large doses.
## Clinical Pearls
* Magnesium sulfate is a vesicant; dilute in an appropriate IV fluid for infusions and administer via a central or large peripheral line.
* Rapid intravenous administration can cause hypotension and cardiac arrhythmias.
* Always assess for signs and symptoms of hypermagnesemia, particularly when treating with high doses or in patients with renal insufficiency.
* For the management of preeclampsia, continued magnesium sulfate therapy post-delivery is often necessary.
***
**Disclaimer:** This information is for educational purposes only and does not substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before administering any medication.
